Piramal Healthcare Limited Says GlaxoSmithKline, Sanofi-Aventis (France) Acquisition Reports Unfounded

February 9, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

MUMBAI (Reuters) - Indian drug maker Piramal Healthcare Ltd (Bombay:PIRA.BO - News) said reports about a potential sale of the company to GlaxoSmithKline Plc (LSE:GSK.L - News) or Sanofi Aventis SA (Paris:SASY.PA - News) were 'unfounded.'

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions Asia

Sanofi GSK